|
Volumn 63, Issue 10, 2014, Pages 1020-1021
|
Yet another player in the cardio-oncology conundrum? Deciphering the role of FLT3
|
Author keywords
apoptosis; heart failure; hematopoietic cytokines; myocardial infarction; receptor tyrosine kinase
|
Indexed keywords
CD135 ANTIGEN;
CRENOLANIB;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ESTAURTINIB;
FLT3 LIGAND;
LESTAURTINIB;
MIDOSTAURIN;
NEU DIFFERENTIATION FACTOR;
PROTEIN KINASE INHIBITOR;
QUIZARTINIB;
SORAFENIB;
SUNITINIB;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
ACUTE CORONARY SYNDROME;
BREAST CANCER;
CANCER PROGNOSIS;
CANCER SURVIVAL;
CARDIOTOXICITY;
CARDIOVASCULAR RISK;
DRUG TARGETING;
ENZYME ACTIVATION;
ENZYME INHIBITION;
FLT3 GENE;
GENE MUTATION;
HEART FAILURE;
HEART INFARCTION;
HEART LEFT VENTRICLE FAILURE;
HEART LEFT VENTRICLE FUNCTION;
HEART PROTECTION;
HUMAN;
HYPERTENSION;
INTRACELLULAR SIGNALING;
MALIGNANT NEOPLASTIC DISEASE;
NONHUMAN; NOTE;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
PROTEIN TARGETING;
RISK FACTOR;
TREATMENT OUTCOME;
CELL SURVIVAL;
DISEASE ASSOCIATION;
DRUG SAFETY;
ENZYME ACTIVITY;
HEART MUSCLE CELL;
MOLECULARLY TARGETED THERAPY;
SIGNAL TRANSDUCTION;
APOPTOSIS;
HEART FAILURE;
HEMATOPOIETIC CYTOKINES;
MYOCARDIAL INFARCTION;
RECEPTOR TYROSINE KINASE;
ANIMALS;
FEMALE;
MEMBRANE PROTEINS;
MYOCARDIAL INFARCTION;
MYOCYTES, CARDIAC;
VENTRICULAR REMODELING;
|
EID: 84896068439
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2013.09.058 Document Type: Editorial |
Times cited : (8)
|
References (9)
|